Taken together, the cumulative evidence now suggests that two alternative pathways, including GNAS-mediated and PTPRK-RSPO3 fusion-mediated mechanisms, may play an important role in the activation of Wnt/beta-catenin signaling in place of APC mutations in Korean CRC lesions. The gene discussed is PTPRK; the disease is colorectal carcinoma.